Altamira Therapeutics Ltd.
(NASDAQ : EARS)

( )
EARS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.76%167.520.0%$1572.37m
NVAXNovavax, Inc. -2.13%90.3678.2%$615.65m
AMGNAmgen, Inc. -1.04%228.901.4%$505.63m
BIIBBiogen, Inc. -2.12%225.911.8%$493.88m
GILDGilead Sciences, Inc. -1.82%67.811.0%$457.06m
BNTXBioNTech SE -3.17%156.530.0%$428.66m
ILMNIllumina, Inc. -1.02%380.443.3%$383.57m
REGNRegeneron Pharmaceuticals, Inc. -0.60%614.382.7%$380.02m
VRTXVertex Pharmaceuticals, Inc. -0.97%228.611.9%$333.31m
SNSSSunesis Pharmaceuticals, Inc. -4.17%2.760.7%$192.93m
EXASEXACT Sciences Corp. -0.13%76.0317.9%$166.25m
ARNAArena Pharmaceuticals, Inc. -0.55%91.0113.7%$134.19m
INCYIncyte Corp. -0.03%74.762.4%$128.59m
ALNYAlnylam Pharmaceuticals, Inc. -0.22%138.318.2%$127.21m
BBIOBridgeBio Pharma, Inc. -2.05%11.460.0%$102.72m

Company Profile

Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.